Literature DB >> 8709215

Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand.

J K Carr1, M O Salminen, C Koch, D Gotte, A W Artenstein, P A Hegerich, D St Louis, D S Burke, F E McCutchan.   

Abstract

Human immunodeficiency virus type 1 isolates of envelope genotype E are contributing substantially to the global pandemic. These strains appear to be mosaics, with the gag gene from clade A and the envelope from clade E; the parental clade E strain has not been found. Here we report the first full genomic sequence of one such mosaic virus, isolate CM240 from Thailand. Multiple breakpoints between the two parental genotypes have been found in a CM240 virus. The entire gag-pol region and most, if not all, of the accessory genes vif, vpr, tat, rev, and vpu appear to derive from clade A. The genotype switches to E shortly after the signal peptide of the envelope and back to clade A near the middle of gp41; thus, the portion of the envelope that lies on the cytoplasmic side of the membrane appears to be principally derived not from clade E, as previously thought, but from clade A. Another small segment not belonging to any recognized clade and presumably also contributed by the parental E strain has been found in the long terminal repeat. It may be significant that the implied virion structure resembles a pseudotype virus with the matrix and core from one clade and the outer envelope from another. In the long terminal repeat, differences were observed between CM240 and other clades in the number of NF-kappa B binding sites, the sequence of the TATA box, and the putative secondary structure of the transactivation response region stem-loop. The mosaic structure of a CM240 virion is suggestive of phenotypic differences which might have contributed to the emergence of this variant.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Asia; Biology; Clinical Research; Developing Countries; Diseases; Genetics; Hiv; Hiv Infections; Research Methodology; Research Report; Southeastern Asia; Thailand; Viral Diseases

Mesh:

Substances:

Year:  1996        PMID: 8709215      PMCID: PMC190613          DOI: 10.1128/JVI.70.9.5935-5943.1996

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials.

Authors:  M L Kalish; A Baldwin; S Raktham; C Wasi; C C Luo; G Schochetman; T D Mastro; N Young; S Vanichseni; H Rübsamen-Waigmann
Journal:  AIDS       Date:  1995-08       Impact factor: 4.177

2.  Determination of HIV-1 subtypes in injecting drug users in Bangkok, Thailand, using peptide-binding enzyme immunoassay and heteroduplex mobility assay: evidence of increasing infection with HIV-1 subtype E.

Authors:  C Wasi; B Herring; S Raktham; S Vanichseni; T D Mastro; N L Young; H Rübsamen-Waigmann; H von Briesen; M L Kalish; C C Luo
Journal:  AIDS       Date:  1995-08       Impact factor: 4.177

3.  Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction.

Authors:  M O Salminen; C Koch; E Sanders-Buell; P K Ehrenberg; N L Michael; J K Carr; D S Burke; F E McCutchan
Journal:  Virology       Date:  1995-10-20       Impact factor: 3.616

4.  Multiple introductions of HIV-1 subtype E into the western hemisphere.

Authors:  A W Artenstein; J Coppola; A E Brown; J K Carr; E Sanders-Buell; E Galbarini; J R Mascola; T C VanCott; P Schonbrood; F E McCutchan
Journal:  Lancet       Date:  1995-11-04       Impact factor: 79.321

5.  Detection of diverse HIV-1 genetic subtypes in the USA.

Authors:  S K Brodine; J R Mascola; P J Weiss; S I Ito; K R Porter; A W Artenstein; F C Garland; F E McCutchan; D S Burke
Journal:  Lancet       Date:  1995-11-04       Impact factor: 79.321

6.  Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden.

Authors:  T Leitner; D Escanilla; S Marquina; J Wahlberg; C Broström; H B Hansson; M Uhlén; J Albert
Journal:  Virology       Date:  1995-05-10       Impact factor: 3.616

7.  Genotypic subtypes of HIV-1 in Cameroon.

Authors:  J N Nkengasong; W Janssens; L Heyndrickx; K Fransen; P M Ndumbe; J Motte; A Leonaers; M Ngolle; J Ayuk; P Piot
Journal:  AIDS       Date:  1994-10       Impact factor: 4.177

Review 8.  The molecular epidemiology of HIV in Asia.

Authors:  B G Weniger; Y Takebe; C Y Ou; S Yamazaki
Journal:  AIDS       Date:  1994       Impact factor: 4.177

Review 9.  Structure, regulation and function of NF-kappa B.

Authors:  U Siebenlist; G Franzoso; K Brown
Journal:  Annu Rev Cell Biol       Date:  1994

10.  Recombination in AIDS viruses.

Authors:  D L Robertson; B H Hahn; P M Sharp
Journal:  J Mol Evol       Date:  1995-03       Impact factor: 2.395

View more
  68 in total

Review 1.  HIV sequence databases.

Authors:  Carla Kuiken; Bette Korber; Robert W Shafer
Journal:  AIDS Rev       Date:  2003 Jan-Mar       Impact factor: 2.500

2.  Identification and genetic characterization of a novel CRF22_01A1 recombinant form of HIV type 1 in Cameroon.

Authors:  Jiangqin Zhao; Shixing Tang; Viswanath Ragupathy; Jean K Carr; Nathan D Wolfe; Bih Awazi; Indira Hewlett
Journal:  AIDS Res Hum Retroviruses       Date:  2010-09       Impact factor: 2.205

3.  The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways.

Authors:  Rajintha M Bandaranayake; Madhavi Kolli; Nancy M King; Ellen A Nalivaika; Annie Heroux; Junko Kakizawa; Wataru Sugiura; Celia A Schiffer
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

4.  Viral evolution and epidemiology.

Authors:  Katrin Leitmeyer; Rebeca Rico-Hesse
Journal:  Curr Opin Infect Dis       Date:  1997-10       Impact factor: 4.915

5.  Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cities.

Authors:  L Heyndrickx; W Janssens; L Zekeng; R Musonda; S Anagonou; G Van der Auwera; S Coppens; K Vereecken; K De Witte; R Van Rampelbergh; M Kahindo; L Morison; F E McCutchan; J K Carr; J Albert; M Essex; J Goudsmit; B Asjö; M Salminen; A Buvé; G van Der Groen
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.

Authors:  H Cao; P Kanki; J L Sankalé; A Dieng-Sarr; G P Mazzara; S A Kalams; B Korber; S Mboup; B D Walker
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes.

Authors:  M A Montano; V A Novitsky; J T Blackard; N L Cho; D A Katzenstein; M Essex
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

8.  Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians.

Authors:  M R Betts; J Krowka; C Santamaria; K Balsamo; F Gao; G Mulundu; C Luo; N N'Gandu; H Sheppard; B H Hahn; S Allen; J A Frelinger
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

9.  Seroincidence of recent human immunodeficiency virus type 1 infections in China.

Authors:  Yao Xiao; Yan Jiang; Jigang Feng; Wenyan Xu; Minjie Wang; Ellen Funkhouser; Sten H Vermund; Yujiang Jia
Journal:  Clin Vaccine Immunol       Date:  2007-08-01

10.  A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1.

Authors:  F Gao; D L Robertson; C D Carruthers; S G Morrison; B Jian; Y Chen; F Barré-Sinoussi; M Girard; A Srinivasan; A G Abimiku; G M Shaw; P M Sharp; B H Hahn
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.